Texas Children’s Cancer Center has the largest and most comprehensive bone tumor research program in the United States. The program is designed to integrate the work of laboratory researchers and translational researchers with clinicians who are directly involved in the care of patients with bone tumors. The common goal is to discover more effective, less toxic treatments for bone tumor patients. Bone tumor research investigators have ongoing studies focused on understanding the pathogenesis, biology and malignant determinants of bone tumors. A major aim is to develop novel approaches that will prevent the development of metastases.
Numerous research investigators at Texas Children's Cancer Center have ongoing studies focused on understanding the pathogenesis, biology, and malignant determinants of bone tumors and developing novel therapies. These studies range from molecular genetic studies, to genomic and proteomic approaches for predicting metastatic behavior of tumors, to novel immunotherapeutic clinical trials for treatment of recurrent or refractory disease.
The Bone Tumor Program aims to integrate basic science researchers who are studying several aspects of bone tumor biology with clinicians who are involved in the care of patients with bone tumors, with the common goal of discovering improved therapies for these patients. The Bone Tumor Program at Texas Children's Cancer Center is associated with Baylor College of Medicine, one of the top medical schools in the country, and Texas Children's Hospital, the largest pediatric hospital in the United States.
RELATED RESEARCH AREAS